Rating Reporting: Northland Capital Analyst Reaffirmed GBX 27.00 Price Target on Techfinancials Inc Ord Usd0.0005 Di (LON:TECH) stock, While Reiterating “Buy” Rating

November 23, 2016 - By Ruchi Gupta

Techfinancials Inc Ord Usd0.0005 Di (LON:TECH) Rating

London: In an analyst report sent to clients and investors on Wednesday, 23 November, Northland Capital maintained their “Buy” rating on shares of Techfinancials Inc Ord Usd0.0005 Di (LON:TECH). They currently have a GBX 27.00 target on the firm. Northland Capital’s target suggests a potential upside of 63.64% from the company’s last stock close.

About 53,750 shares traded hands or 785.21% up from the average. TechFinancials Inc (LON:TECH) has risen 25.00% since April 25, 2016 and is uptrending. It has outperformed by 19.67% the S&P500.

Insitutional Activity: The institutional sentiment decreased to 0.97 in Q2 2016. Its down 0.15, from 1.12 in 2016Q1. The ratio is negative, as 15 funds sold all TechFinancials Inc shares owned while 93 reduced positions. 40 funds bought stakes while 81 increased positions. They now own 36.18 million shares or 1.56% less from 36.75 million shares in 2016Q1.

Whittier Of Nevada Inc holds 0% or 250 shares in its portfolio. Utah Retirement has 0.02% invested in the company for 6,747 shares. Btim Corporation has 142,724 shares for 0.27% of their US portfolio. Price T Rowe Assoc Inc Md accumulated 0% or 17,207 shares. Sandler Mgmt holds 0.94% or 63,440 shares in its portfolio. Moreover, Sit Inv Assocs has 0.03% invested in TechFinancials Inc (LON:TECH) for 8,775 shares. Jane Street Grp Inc Ltd Liability Corporation has 4,133 shares for 0% of their US portfolio. Confluence Invest Mgmt Ltd Liability Company last reported 0.07% of its portfolio in the stock. Bluecrest Cap Management last reported 0.04% of its portfolio in the stock. Bamco Inc Ny accumulated 0.98% or 1.64 million shares. Next Fincl Grp Inc Inc last reported 512 shares in the company. Kornitzer Capital Mngmt Ks holds 261,615 shares or 0.53% of its portfolio. Balyasny Asset Management Lc holds 4,892 shares or 0% of its portfolio. Neuberger Berman Grp Limited Liability Corp has 1.54M shares for 0.24% of their US portfolio. Dimensional Fund Advsrs Limited Partnership last reported 173,713 shares in the company.

Insider Transactions: Since June 15, 2016, the stock had 0 insider purchases, and 10 insider sales for $1.38 million net activity. Gould Kevin S sold $57,904 worth of stock or 524 shares. 1,700 TechFinancials Inc (LON:TECH) shares with value of $186,716 were sold by HIGGINS JOHN L. On Thursday, September 1 the insider BAUMGARTNER ROBERT V sold $693,039. 100 shares with value of $11,370 were sold by LUCAS ROGER C on Wednesday, August 17.

TechFinancials Inc is a software developer, supplying a trading solution to online brokers through whom its software is used by traders across the world. The company has a market cap of 10.83 million GBP. The Firm supplies software and services to brokers in the binary options market and operates its own online broker, www.OptionFair.com. It has a 15.17 P/E ratio. The Company’s www.OptionFair.com enables the Company to trial and evaluate products that it has under development.

According to Zacks Investment Research, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.”

TECH Company Profile

Bio-Techne Corporation, incorporated on July 17, 1981, develops, makes and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Firm operates through three divisions: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, makes and sells biotechnology research and diagnostic products across the world. The Clinical Controls segment develops and makes controls, calibrators, immunoassays and other reagents for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis.

Another recent and important TechFinancials Inc (LON:TECH) news was published by Uk.Finance.Yahoo.com which published an article titled: “TechFinancials, Inc. (TECH.L)” on March 27, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News